The aim of this thesis was to evaluate the potential of poly(D,L-lactide-co-glycolide) and alginate particles as nasal delivery system for antigen, using influenza virus antigen as a model. This work is ase on the hypothesis that polymeric particles ( The study was divided in three major steps. The first step was to formulate poly(D,L-lactide-co-glycolide) and alginate particles. The formulation, which is essential during the development of an antigen delivery system, comprised the polymeric particle preparation and characterization/ the former included the analysis of the particle morphology, the determination of the particle size and size distribution, the study of the particle biodegradation, the determination of the protein loading, the...
International audienceInfluenza vaccines administered intramuscularly exhibit poor mucosal immune re...
Polymeric nano/microparticles as vaccine adjuvants have been researched in experimental and clinical...
Thesis (Ph.D.)--University of Washington, 2014The key aspect of a vaccine delivery platform is to be...
The aim of this study was to evaluate the potential of poly(D,L-lactide-co-glycolide) nano-and micro...
One of the key requirements for successful vaccination via the mucosa is particulate antigen uptake....
The continuous emergence of new pathogens and growing drug resistance of microorganisms asks for inn...
The objective of this work was to conduct an in vivo comparison of nanoparticles and microparticles ...
The goal of this study was to evaluate the technological feasibility of delivering antigen using alg...
In this project, antigen-containing microspheres were produced using a range of biodegradable polyme...
The objective of this work was to develop a new delivery system which could enhance the mucosal immu...
The goal of this study was to evaluate the technological feasibility of delivering antigen using alg...
For efficient mucosal vaccine delivery, nanoparticulate antigens are better taken by microfold cells...
In this study, we demonstrate how encapsulating a conserved influenza ectodomain matrix-2 protein vi...
Nasal vaccination is a promising, needle-free alternative to classical vaccination. Nanoparticulate ...
Background: Antibodies are immune proteins that have been developed into therapeutic agents due to t...
International audienceInfluenza vaccines administered intramuscularly exhibit poor mucosal immune re...
Polymeric nano/microparticles as vaccine adjuvants have been researched in experimental and clinical...
Thesis (Ph.D.)--University of Washington, 2014The key aspect of a vaccine delivery platform is to be...
The aim of this study was to evaluate the potential of poly(D,L-lactide-co-glycolide) nano-and micro...
One of the key requirements for successful vaccination via the mucosa is particulate antigen uptake....
The continuous emergence of new pathogens and growing drug resistance of microorganisms asks for inn...
The objective of this work was to conduct an in vivo comparison of nanoparticles and microparticles ...
The goal of this study was to evaluate the technological feasibility of delivering antigen using alg...
In this project, antigen-containing microspheres were produced using a range of biodegradable polyme...
The objective of this work was to develop a new delivery system which could enhance the mucosal immu...
The goal of this study was to evaluate the technological feasibility of delivering antigen using alg...
For efficient mucosal vaccine delivery, nanoparticulate antigens are better taken by microfold cells...
In this study, we demonstrate how encapsulating a conserved influenza ectodomain matrix-2 protein vi...
Nasal vaccination is a promising, needle-free alternative to classical vaccination. Nanoparticulate ...
Background: Antibodies are immune proteins that have been developed into therapeutic agents due to t...
International audienceInfluenza vaccines administered intramuscularly exhibit poor mucosal immune re...
Polymeric nano/microparticles as vaccine adjuvants have been researched in experimental and clinical...
Thesis (Ph.D.)--University of Washington, 2014The key aspect of a vaccine delivery platform is to be...